Literature DB >> 31811777

B cell clonal expansion within immune infiltrates in human cardiac allograft vasculopathy.

Carolina Moore1,2,3, Baoshan Gao1,4, Krishna M Roskin2,3,5, Elena-Rodica M Vasilescu6, Linda Addonizio7, Michael M Givertz8, Joren C Madsen1,9, Emmanuel Zorn1,10.   

Abstract

Cardiac allograft vasculopathy (CAV) is associated with intragraft B cell infiltrates. Here, we studied the clonal composition of B cell infiltrates using 4 graft specimens with CAV. Using deep sequencing, we analyzed the immunoglobulin heavy chain variable region repertoire in both graft and blood. Results showed robust B cell clonal expansion in the graft but not in the blood for all cases. Several expanded B cell clones, characterized by their uniquely rearranged complementarity-determining region 3, were detected in different locations in the graft. Sequences from intragraft B cells also showed elevated levels of mutated rearrangements in the graft compared to blood B cells. The number of somatic mutations per rearrangement was also higher in the graft than in the blood, suggesting that B cells continued maturing in situ. Overall, our studies demonstrated B cell clonal expansion in human cardiac allografts with CAV. This local B cell response may contribute to the pathophysiology of CAV through a mechanism that needs to be identified.
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  B cell biology; basic (laboratory) research/science; heart (allograft) function/dysfunction; heart transplantation/cardiology; immunobiology; rejection: chronic

Mesh:

Year:  2019        PMID: 31811777      PMCID: PMC7238293          DOI: 10.1111/ajt.15737

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  32 in total

Review 1.  Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy.

Authors:  M R Mehra
Journal:  Am J Transplant       Date:  2006-06       Impact factor: 8.086

Review 2.  Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors?

Authors:  Jennifer R Wehner; William M Baldwin
Journal:  Curr Opin Organ Transplant       Date:  2010-10       Impact factor: 2.640

Review 3.  The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.

Authors:  Héloise Cardinal; Mélanie Dieudé; Marie-Josée Hébert
Journal:  J Am Soc Nephrol       Date:  2016-10-17       Impact factor: 10.121

4.  Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation.

Authors:  Randall C Starling; Brian Armstrong; Nancy D Bridges; Howard Eisen; Michael M Givertz; Abdallah G Kfoury; Jon Kobashigawa; David Ikle; Yvonne Morrison; Sean Pinney; Josef Stehlik; Sudipta Tripathi; Mohamed H Sayegh; Anil Chandraker
Journal:  J Am Coll Cardiol       Date:  2019-07-09       Impact factor: 24.094

5.  The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.

Authors:  Manon M H Huibers; Alison J Gareau; Aryan Vink; Rianne Kruit; Hannah Feringa; Johanna M T Beerthuijzen; Erica Siera-de Koning; Ton Peeters; Nicolaas de Jonge; Roel A de Weger; Timothy D G Lee
Journal:  J Heart Lung Transplant       Date:  2014-12-08       Impact factor: 10.247

Review 6.  Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy.

Authors:  Manon A A Jansen; Henny G Otten; Roel A de Weger; Manon M H Huibers
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

Review 7.  The importance of non-HLA antibodies in transplantation.

Authors:  Qiuheng Zhang; Elaine F Reed
Journal:  Nat Rev Nephrol       Date:  2016-06-27       Impact factor: 28.314

8.  Rituximab as treatment for refractory kidney transplant rejection.

Authors:  Yolanda T Becker; Bryan N Becker; John D Pirsch; Hans W Sollinger
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

9.  Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts.

Authors:  M M H Huibers; A J Gareau; J M T Beerthuijzen; E Siera-de Koning; J van Kuik; E G Kamburova; A Vink; N de Jonge; T D G Lee; H G Otten; R A de Weger
Journal:  Am J Transplant       Date:  2016-08-18       Impact factor: 8.086

10.  IgBLAST: an immunoglobulin variable domain sequence analysis tool.

Authors:  Jian Ye; Ning Ma; Thomas L Madden; James M Ostell
Journal:  Nucleic Acids Res       Date:  2013-05-13       Impact factor: 16.971

View more
  2 in total

Review 1.  Analysis of T-Cell Receptor Repertoire in Transplantation: Fingerprint of T Cell-mediated Alloresponse.

Authors:  Guangyao Tian; Mingqian Li; Guoyue Lv
Journal:  Front Immunol       Date:  2022-01-12       Impact factor: 7.561

2.  T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy.

Authors:  Marlena V Habal; April M I Miller; Samhita Rao; Sijie Lin; Aleksandar Obradovic; Mohsen Khosravi-Maharlooei; Sarah B See; Poulomi Roy; Ronzon Shihab; Siu-Hong Ho; Charles C Marboe; Yoshifumi Naka; Koji Takeda; Susan Restaino; Arnold Han; Donna Mancini; Michael Givertz; Joren C Madsen; Megan Sykes; Linda J Addonizio; Maryjane A Farr; Emmanuel Zorn
Journal:  Am J Transplant       Date:  2020-10-26       Impact factor: 8.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.